{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:13:42Z","timestamp":1782868422039,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["728218"],"award-info":[{"award-number":["728218"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-05-00282"],"award-info":[{"award-number":["20-05-00282"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07677-4","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T10:08:29Z","timestamp":1662199709000},"page":"460-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-2415","authenticated-orcid":false,"given":"Ondrej","family":"Fabian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Klocperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Lerchova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Jencova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Stolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Belhajova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Voriskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Kazeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Vicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hradsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bronsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"issue":"6","key":"7677_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R et al. Third european evidence-based consensus on diagnosis and management of ulcerative colitis Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649\u2013670.","journal-title":"J Crohns Colitis."},{"issue":"1","key":"7677_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V et al. 3rd european evidence-based consensus on the diagnosis and management of crohn\u2019s disease 2016: Part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325.","journal-title":"J Crohns Colitis."},{"issue":"2","key":"7677_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ibd.23013","volume":"19","author":"A Levine","year":"2013","unstructured":"Levine A, de Bie CL, Turner D et al. Atypical disease phenotypes in paediatric ulcerative colitis: 5-year analyses of the EUROKIDS registry. Inflamm Bowel Dis. 2013;19:370\u2013377.","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"7677_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/MIB.0000000000000483","volume":"21","author":"AD Winter","year":"2015","unstructured":"Winter AD, Karolewska-Bochenek K, Lazowska-Przeorek I et al. Pediatric IBD-unclassified is less common than previously reported; Results of an 8-year audit of the EUROKIDS registry. Inflamm Bowel Dis. 2015;21:2145\u20132153.","journal-title":"Inflamm Bowel Dis."},{"issue":"41","key":"7677_CR5","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.3748\/wjg.v18.i41.5862","volume":"18","author":"AS Day","year":"2012","unstructured":"Day AS, Ledder O, Leach ST et al. Crohn\u2019s and colitis in children and adolescents. World J Gastroenterol. 2012;18:5862\u20135869.","journal-title":"World J Gastroenterol."},{"issue":"3","key":"7677_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.gtc.2014.05.003","volume":"43","author":"M Dave","year":"2014","unstructured":"Dave M, Papadakis KA, Faubion WA Jr. Immunology of inflammatory bowel disease and molecular targets for biologics. Gastroenterol Clin North Am. 2014;43:405\u2013424.","journal-title":"Gastroenterol Clin North Am."},{"issue":"9","key":"7677_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ibd\/izz049","volume":"25","author":"B Roosenboom","year":"2019","unstructured":"Roosenboom B, Wahab PJ, Smids C et al. Intestinal CD103+CD4+ and CD103+CD8+ T-cell subsets in the gut of inflammatory bowel disease patients at diagnosis and during follow-up. Inflamm Bowel Dis. 2019;25:1497\u20131509.","journal-title":"Inflamm Bowel Dis."},{"issue":"8","key":"7677_CR8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1097\/MIB.0000000000000811","volume":"22","author":"J Li","year":"2016","unstructured":"Li J, Ueno A, Gasia MF et al. Profiles of lamina propria T helper cell subsets discriminate between ulcerative colitis and crohn\u2019s disease. Inflamm Bowel Dis. 2016;22:1779\u20131792.","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"7677_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/ecco-jcc\/jjv097","volume":"9","author":"C Flores","year":"2015","unstructured":"Flores C, Francesconi CF, Meurer L. Quantitative assessment of CD30+ lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease. J Crohns Colitis. 2015;9:763\u2013768.","journal-title":"J Crohns Colitis."},{"key":"7677_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/928461","volume":"2014","author":"J Galvez","year":"2014","unstructured":"Galvez J. Role of Th17 cells in the pathogenesis of human IBD. ISRN Inflamm. 2014;2014:928461.","journal-title":"ISRN Inflamm."},{"issue":"1","key":"7677_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ibd.21403","volume":"17","author":"SY Salim","year":"2011","unstructured":"Salim SY, S\u00f6derholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362\u2013381.","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"7677_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1365-2249.1998.00532.x","volume":"111","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Passacantando A, Parzanese I et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn\u2019s disease (CD). Clin Exp Immunol. 1998;111:532\u2013535.","journal-title":"Clin Exp Immunol."},{"issue":"7","key":"7677_CR13","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s10620-018-5018-3","volume":"63","author":"O Fabian","year":"2018","unstructured":"Fabian O, Hradsky O, Drskova T et al. Immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of pediatric ulcerative colitis. Dig Dis Sci. 2018;63:1811\u20131818.","journal-title":"Dig Dis Sci."},{"issue":"6","key":"7677_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","volume":"58","author":"A Levine","year":"2014","unstructured":"Levine A, Koletzko S, Turner D et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795\u2013806.","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"12","key":"7677_CR15","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.crohns.2014.08.011","volume":"8","author":"RV Bryant","year":"2014","unstructured":"Bryant RV, Winer S, Travis SP et al. Systematic review: histological remission in inflammatory bowel disease Is \u2018complete\u2019 remission the new treatment paradigm? An IOIBD initiative. J Crohns Colitis. 2014;8:1582\u20131597.","journal-title":"An IOIBD initiative. J Crohns Colitis."},{"issue":"4","key":"7677_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G et al. Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc. 2004;60:505\u2013512.","journal-title":"Gastrointest Endosc."},{"issue":"4","key":"7677_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.crohns.2011.10.005","volume":"6","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan U, Kochhar G, Phull H et al. Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients. J Crohns Colitis. 2012;6:470\u2013475.","journal-title":"J Crohns Colitis."},{"issue":"4","key":"7677_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology. 1990;99:956\u2013963.","journal-title":"Gastroenterology."},{"issue":"1","key":"7677_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ibd.21649","volume":"18","author":"D Turner","year":"2012","unstructured":"Turner D, Griffiths AM, Walters TD et al. Mathematical weighting of the pediatric Crohn\u2019s disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55\u201362.","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"7677_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","volume":"133","author":"D Turner","year":"2007","unstructured":"Turner D, Otley AR, Mack D et al. Development and evaluation of a pediatric ulcerative colitis activity index (PUCAI): a prospective multicenter study. Gastroenterology. 2007;133:423\u2013432.","journal-title":"Gastroenterology."},{"issue":"1","key":"7677_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","volume":"85","author":"B Falini","year":"1995","unstructured":"Falini B, Pileri S, Pizzolo G et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood. 1995;85:1\u201314.","journal-title":"Blood."},{"issue":"2","key":"7677_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550\u2013564.","journal-title":"Gastroenterology."},{"issue":"1","key":"7677_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1096\/fasebj.9.1.7821763","volume":"9","author":"G del Prette","year":"1995","unstructured":"del Prette G, de Carli M, Almerigogna F et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 1995;9:81\u201386.","journal-title":"FASEB J."},{"issue":"8","key":"7677_CR24","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10620-012-2129-0","volume":"57","author":"S Somada","year":"2012","unstructured":"Somada S, Muta H, Nakamura K et al. CD30 ligand\/CD30 interaction is involved in pathogenesis of inflammatory bowel disease. Dig Dis Sci. 2012;57:2031\u20132037.","journal-title":"Dig Dis Sci."},{"issue":"12","key":"7677_CR25","first-page":"2083","volume":"8","author":"HJ Gruss","year":"1994","unstructured":"Gruss HJ, DaSilva N, Hu ZB et al. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia. 1994;8:2083\u20132094.","journal-title":"Leukemia."},{"issue":"7","key":"7677_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/labinvest.3780117","volume":"80","author":"PL Hsu","year":"2000","unstructured":"Hsu PL, Hsu SM. Autocrine growth regulation of CD30 ligand in CD30-expressing reed-sternberg cells: distinction between hodgkin\u2019s disease and anaplastic large cell lymphoma. Lab Invest. 2000;80:1111\u20131119.","journal-title":"Lab Invest."},{"issue":"19","key":"7677_CR27","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","volume":"363","author":"A Younes","year":"2010","unstructured":"Younes A, Bartlett NL, Leonard JP et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2010;363:1812\u20131821.","journal-title":"N Engl J Med."},{"issue":"32","key":"7677_CR28","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","volume":"33","author":"M Duvic","year":"2015","unstructured":"Duvic M, Tetzlaff MT, Gangar P et al. Results of a phase II trial of brentuximab vedotin for CD30+ Cutaneous T-cell lymphoma and lymphomatoid papulosis. J Clin Oncol. 2015;33:3759\u20133765.","journal-title":"J Clin Oncol."},{"issue":"11","key":"7677_CR29","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1097\/MIB.0000000000000203","volume":"20","author":"CSHT Horje","year":"2014","unstructured":"Horje CSHT, Middendorp S, van Koolwijk E et al. Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1902\u20131909.","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"7677_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1203\/PDR.0b013e318163a897","volume":"63","author":"N Holland","year":"2008","unstructured":"Holland N, Dong J, Garnett E et al. Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn\u2019s disease and age-related changes in Th1\/Th2 cytokine profiles. Pediatr Res. 2008;63:257\u2013262.","journal-title":"Pediatr Res."},{"issue":"2","key":"7677_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2249.2003.02155.x","volume":"132","author":"Y Jo","year":"2003","unstructured":"Jo Y, Matsumoto T, Yada S et al. CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn\u2019s disease. Clin Exp Immunol. 2003;132:332\u2013338.","journal-title":"Clin Exp Immunol."},{"issue":"47","key":"7677_CR32","first-page":"6001","volume":"16","author":"A Cseh","year":"2010","unstructured":"Cseh A, Vasarhelyi B, Molnar K et al. Immune phenotype in children with therapy-na\u00efve remitted and relapsed Crohn\u2019s disease. World J Gastroenterol. 2010;16:6001\u20136009.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"7677_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10875-009-9345-1","volume":"30","author":"N Eastaff-Leung","year":"2010","unstructured":"Eastaff-Leung N, Mabarrack N, Barbour A et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30:80\u201389.","journal-title":"J Clin Immunol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07677-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:53:47Z","timestamp":1675842827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07677-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7677"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07677-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Legal representatives of patients signed an informed consent form for inclusion in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Motol University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}